Most-read stories on, January 2023

COURTESY RHODE ISLAND HOSPITAL 1. Lifespan announces ‘breakthrough’ in brain cancer research POSTED ONLINE: JAN. 6. Lifespan Cancer Institute researchers said the phase 3 trial of the DCVax-L vaccine showed improved survival rates in patients with newly diagnosed and returning glioblastoma, the most common and most lethal form of brain cancer.   2.

Already a Subscriber? Log in

To Continue Reading This Article

Become a Providence Business News subscriber and get immediate access to all of our premier content and much more.

Learn More and Become a Subscriber